Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.21.2
Condensed Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenues $ 1,010 $ 1,284 $ 7,773 $ 1,316
Cost of revenues (1,043) (883) (5,191) (894)
Gross profit (loss) (33) 401 2,582 422
Research and development expenses (166) (9,086) (685) (9,655)
Sales and marketing expenses (429) (757) (2,387) (2,187)
General and administrative expenses (1,869) (804) (5,198) (1,729)
Operating loss (2,497) (10,246) (5,688) (13,149)
Financing expenses, net (6,875) (7,055) (17,360) (11,375)
Share in losses of affiliated companies accounted for under equity method, net (1,007) (734) (1,499) (734)
Net loss $ (10,379) $ (18,035) $ (24,547) $ (25,258)
Basic and diluted net loss per share $ (0.01) $ (0.07) $ (0.04) $ (0.12)
Weighted average number of ordinary shares outstanding attributable to ordinary shareholders used in computation of basic and diluted net loss per share 736,939,641 257,276,039 637,916,356 210,806,186